Evidence map›Paper›PMID 31035290›Full record

ArticleAnnals of internal medicine2019

Precision Medicine in Internal Medicine.

Krzysztof Kiryluk, David B Goldstein, John W Rowe, Ali G Gharavi, Ronald Wapner, Wendy K Chung

Abstract read
In one paragraph

Article in Annals of internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Krzysztof KirylukCollege of Physicians and Surgeons, Columbia University, New York, New York (K.K., D.B.G., A.G.G., R.W., W.K.C.).
David B GoldsteinCollege of Physicians and Surgeons, Columbia University, New York, New York (K.K., D.B.G., A.G.G., R.W., W.K.C.).
John W RoweMailman School of Public Health, Columbia University, New York, New York (J.W.R.).
Ali G GharaviCollege of Physicians and Surgeons, Columbia University, New York, New York (K.K., D.B.G., A.G.G., R.W., W.K.C.).
Ronald WapnerCollege of Physicians and Surgeons, Columbia University, New York, New York (K.K., D.B.G., A.G.G., R.W., W.K.C.).
Wendy K ChungCollege of Physicians and Surgeons, Columbia University, New York, New York (K.K., D.B.G., A.G.G., R.W., W.K.C.).

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
OMOP information model for eMERGE phenotypingU01HG008680 · NHGRI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Wendy K Chung, GEORGE M HRIPCSAK · 2015 to 2026
$13.3M
Columbia/Cornell/Harlem Hospital Precision Medicine Initiative HPOUG3OD023183 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GHARAVI, ALI G, GOLDSTEIN, DAVID B. · 2016 to 2017
$6.8M
Kidney Precision Medicine Program (KPMP): Columbia AKI Recruitment SiteUH3DK114926 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARASCH, JONATHAN M., BOMBACK, ANDREW STEPHEN · 2019 to 2021
$900k
Kidney Precision Medicine Program (KPMP): Columbia AKI Recruitment SiteUG3DK114926 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARASCH, JONATHAN M., BOMBACK, ANDREW STEPHEN · 2017 to 2018
$747k
NCATS NIH HHS UL1 TR001873NHGRI NIH HHS U01 HG008680NIDDK NIH HHS UG3 DK114926NIDDK NIH HHS UH3 DK114926NIH HHS UG3 OD023183
6 · The paper itself

Abstract

Medicine has long sought to match diagnostic and treatment approaches to the particular needs and risks of individual patients. The decreasing cost and increasing ease of genetic sequencing have propelled the rise of precision medicine. Precision medicine aims to use genetic and other information to provide care tailored to the individual patient, with the goal of improving clinical outcomes and minimizing unnecessary diagnostic and therapeutic interventions. Although developments in genetic sequencing have the potential to transform clinical care, there are important limitations, including uncertainty in the clinical interpretation of many genetic variants and concerns about privacy, discrimination, and cost. To help clinicians understand the basics of genetic sequencing and how to apply it in clinical practice, Annals of Internal Medicine is launching a new "Precision Medicine" series. This introduction provides a general overview of clinical sequencing, with a focus on germline variation. Subsequent articles will use a case-based format to provide concise summaries of specific clinical precision medicine scenarios that are relevant to the practice of internal medicine. These cases will highlight specific clinical indications; interpretation of genetic test results; and ethical, legal, cost, and privacy issues related to genetic testing. The goal is to provide practical information on the appropriate application and interpretation of genomics in routine clinical practice.

Indexed as

Genetic TestingInternal MedicinePrecision MedicineSequence Analysis, DNADatabases, Nucleic AcidGenetic Carrier ScreeningGenetic Predisposition to DiseaseGenetic PrivacyGenetic VariationHumansIncidental FindingsInsurance CoverageInsurance, HealthUncertainty

Identifiers

PMID31035290
PMCPMC7437606

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.